Patents by Inventor Abdelrahman S. Mayhoub

Abdelrahman S. Mayhoub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10414759
    Abstract: Series of 2-phenyl-4-methylthiazole analogs are disclosed as potential therapeutic agents for the treatment of bacterial infections, especially methicillin-resistant Straphylococcus aureus (MRSA) related infections. A method for the treatment of MRSA-related infections is also claimed.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: September 17, 2019
    Assignee: Purdue Research Foundation
    Inventors: Mark S. Cushman, Abdelrahman S. Mayhoub, Mohamed Seleem
  • Publication number: 20180319784
    Abstract: Series of 2-phenyl-4-methylthiazole analogues are disclosed as potential therapeutic agents for the treatment of bacterial infections, especially methicillin-resistant Straphylococcus aureus (MRSA) related infections. A method for the treatment of MRSA-related infections is also claimed.
    Type: Application
    Filed: May 8, 2018
    Publication date: November 8, 2018
    Applicant: Purdue Research Foundation
    Inventors: Mark S. Cushman, Abdelrahman S. Mayhoub, Mohamed Seleem
  • Patent number: 9801861
    Abstract: Disclosed are compositions having activity against MRSA and/or VRSA, and methods of using the compositions to treat microbial infections.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 31, 2017
    Assignee: Purdue Research Foundation
    Inventors: Mark Stanley Cushman, Mohamed Seleem, Abdelrahman S Mayhoub
  • Publication number: 20160243088
    Abstract: Disclosed are compositions having activity against MRSA and/or VRSA, and methods of using the compositions to treat microbial infections.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 25, 2016
    Inventors: Mark Stanley Cushman, Mohamed Seleem, Abdelrahman S. Mayhoub
  • Patent number: 9353072
    Abstract: Disclosed are compositions having activity against MRSA and/or VRSA, and methods of using the compositions to treat microbial infections.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: May 31, 2016
    Assignee: Purdue Research Foundation
    Inventors: Mark Stanley Cushman, Mohamed Seleem, Abdelrahman S Mayhoub
  • Publication number: 20140121249
    Abstract: Disclosed are compositions having activity against MRSA and/or VRSA, and methods of using the compositions to treat microbial infections.
    Type: Application
    Filed: October 31, 2013
    Publication date: May 1, 2014
    Inventors: Mark Stanley Cushman, Mohamed Seleem, Abdelrahman S. Mayhoub